HPV: A Brief Overview and Recommendations for Pharmacists
HPV: A Brief Overview and Recommendations for Pharmacists
The Advisory Committee on Immunization Practices (ACIP) currently recommends routine vaccination of adolescents aged 11 or 12 years with either HPV4 (males and females) or HPV2 (females only). To be considered fully immunized, individuals must complete a three-dose series. Either vaccine product series can be initiated in individuals as young as 9 years old; catch-up vaccination is indicated for females between the ages of 13 and 26 years and males aged 13–21 years who have never received a dose or who have not yet completed the entire series.
HPV vaccine-type prevalence has decreased by more than than 50% since introduction of the quadrivalent vaccine in mid-2006, according to a National Health and Nutrition Examination Surveys (NHANES) study that examined cervicovaginal swabs from females aged 14–59 years. In addition to demonstrated efficacy, both vaccines have been shown to be safe based on a multifaceted surveillance system.
HPV Vaccine Overview
The Advisory Committee on Immunization Practices (ACIP) currently recommends routine vaccination of adolescents aged 11 or 12 years with either HPV4 (males and females) or HPV2 (females only). To be considered fully immunized, individuals must complete a three-dose series. Either vaccine product series can be initiated in individuals as young as 9 years old; catch-up vaccination is indicated for females between the ages of 13 and 26 years and males aged 13–21 years who have never received a dose or who have not yet completed the entire series.
HPV vaccine-type prevalence has decreased by more than than 50% since introduction of the quadrivalent vaccine in mid-2006, according to a National Health and Nutrition Examination Surveys (NHANES) study that examined cervicovaginal swabs from females aged 14–59 years. In addition to demonstrated efficacy, both vaccines have been shown to be safe based on a multifaceted surveillance system.
Source...